SCA Pharma February 2021 Report
Snapshot
Total Users
4,157 New Users
Total Pageviews
9,528 Unique Pageviews
Sessions
1.71 Pages/Session
Avg. Time on Page
%
Bounce Rate
Compare to January 2021:
Total Users
4,585 New Users
Total Pageviews
10,730 Unique Pageviews
Sessions
1.75 Pages/Session
Avg. Time on Page
%
Bounce Rate
Key Insights
| Page | Pageviews | Unique Pageviews | Avg. Time on Page | Entrances | Bounce Rate | % Exit | |
| 1 | / | 4,567 | 4,056 | 0:01:38 | 3,952 | 37.2% | 64.9% |
| 2 | /products/ | 704 | 572 | 0:01:40 | 190 | 50.8% | 54.1% |
| 3 | /careers/ | 698 | 549 | 0:03:20 | 230 | 47.8% | 68.9% |
| 4 | /sca-pharmaceuticals-appoints-joe-akers-as-chief-operating-officer/ | 675 | 621 | 0:02:35 | 550 | 83.1% | 78.5% |
| 5 | /sca-pharmaceuticals-appoints-chief-commercial-officer/ | 561 | 536 | 0:01:57 | 390 | 87.4% | 73.6% |
| 6 | /the-vistria-group-and-excellere-capital-management-invest-in-sca-pharmaceuticals/ | 478 | 437 | 0:02:13 | 125 | 80.0% | 50.8% |
| 7 | /contact-page/ | 452 | 368 | 0:01:46 | 147 | 66.0% | 57.7% |
| 8 | /our-team/ | 385 | 272 | 0:00:55 | 68 | 41.2% | 25.7% |
| 9 | /why-sca/ | 235 | 192 | 0:01:08 | 18 | 61.1% | 35.3% |
| 10 | /why-outsource-503b/ | 198 | 180 | 0:01:20 | 20 | 85.0% | 37.4% |
| Region | Users | New Users | Sessions | Bounce Rate | Pages / Session | Avg. Session Duration | |
| 1 | Connecticut | 632 | 537 | 773 | 59.9% | 1.86 | 0:01:16 |
| 2 | Illinois | 531 | 501 | 630 | 68.1% | 1.89 | 0:01:10 |
| 3 | Texas | 353 | 311 | 479 | 52.4% | 1.59 | 0:01:05 |
| 4 | California | 241 | 195 | 384 | 30.0% | 1.44 | 0:01:03 |
| 5 | New York | 239 | 189 | 423 | 29.8% | 1.76 | 0:01:26 |
| 6 | Arkansas | 189 | 159 | 227 | 35.2% | 2.36 | 0:01:52 |
| 7 | Virginia | 174 | 148 | 238 | 54.2% | 1.27 | 0:01:00 |
| 8 | Pennsylvania | 151 | 107 | 256 | 28.1% | 1.4 | 0:00:44 |
| 9 | Massachusetts | 146 | 118 | 192 | 49.0% | 2.07 | 0:01:28 |
| 10 | Florida | 143 | 124 | 208 | 44.7% | 1.62 | 0:00:59 |
| Default Channel Grouping | Users | New Users | Sessions | Bounce Rate | Pages / Session | Avg. Session Duration | |
| 1 | Organic Search | 2,112 | 1,737 | 2,981 | 33.6% | 2.09 | 0:01:41 |
| 2 | Direct | 1,780 | 1,594 | 2,441 | 58.9% | 1.39 | 0:00:46 |
| 3 | Social | 845 | 770 | 892 | 82.7% | 1.29 | 0:00:32 |
| 4 | Referral | 71 | 58 | 84 | 57.1% | 1.8 | 0:01:26 |
February 2021 Emails
| Time Sent | Campaign Name | Sends | Opens | Open Rate | Clicks | Click Rate | Bounces | Bounce Rate | Unsubs | |
| 1 | 2/4/21 | February Updates – SCA Employees | 34 | 26 | 78.8% | 1 | 3.8% | 1 | 2.9% | 0 |
| 2 | 2/4/21 | February Updates – Sterling Customers | 250 | 46 | 20.6% | 15 | 32.6% | 27 | 10.8% | 0 |
| 3 | 2/5/21 | February Updates – All Customers | 5,048 | 1,024 | 23.2% | 378 | 36.9% | 634 | 12.6% | 2 |
February 2021 LinkedIn Data
LI Pageviews
717 Desktop LI Pageviews
615 Mobile LI Pageviews
Total Followers
70 New Followers in February
Top 5 Visitor Locations
- Greater Chicago Area
- Hartford, CT Area
- Greater NYC Area
- Greater Boston Area
- Greater Philadelphia Area
| Update link | Post date | Impressions | Clicks | CTR | Likes | Comments | Shares | Engage. rate | |
| 1 | linkedin.com | 2/3/21 | 795 | 21 | 2.6% | 24 | 2 | 14 | 7.7% |
| 2 | linkedin.com | 2/9/21 | 494 | 14 | 2.8% | 10 | 0 | 3 | 5.5% |
| 3 | linkedin.com | 2/15/21 | 642 | 32 | 5.0% | 33 | 0 | 15 | 12.5% |
| 4 | linkedin.com | 2/16/21 | 452 | 10 | 2.2% | 6 | 0 | 2 | 4.0% |
| 5 | linkedin.com | 2/18/21 | 6831 | 560 | 8.2% | 121 | 45 | 15 | 10.8% |
| 6 | linkedin.com | 2/23/21 | 613 | 31 | 5.1% | 29 | 0 | 15 | 12.2% |
| 7 | linkedin.com | 2/24/21 | 353 | 16 | 4.5% | 17 | 0 | 15 | 13.6% |
February 2021 Google Ads Data
| Ad type | Final URL | Headlines and Descriptions | Clicks | Impr. | CTR | Avg. CPC | Cost | ||||
| 1 | Responsive search ad | https://scapharma.com/ | SCA Pharma | 503B Outsourcing Facility | Pharmaceutical Quality System | State-of-the-art Facilities | 271 | 20,921 | 1.30% | $0.46 | $125.53 |
| Outsourcing 503B | Leading 503B Organization | Outstanding 503B Quality | Outsource Sterile Compounding | ||||||||
| Descriptions: 1. SCA Pharma features state-of-the-art production facilities designed with quality in mind. 2. A 503B outsourcing facility providing the highest quality sterile compounded products. 3.SCA Pharma offers an extensive product portfolio and outstanding quality. 4. Contact SCA Pharma to discuss your 503B outsourcing needs. | |||||||||||
| 2 | Expanded text ad | https://scapharma.com/ | FDA 503B Outsourcing Facility | SCA Pharma | — | — | 23 | 6,702 | 0.34% | $0.55 | $ 12.60 |
| Descriptions: 1. SCA Pharma is a leader in defining Quality for the 503B Outsourcing market. 2. The result is that you can depend on us to deliver safe and effective medicines. | |||||||||||
| 3 | Expanded text ad | https://scapharma.com/ | SCA Pharma | 503B Outsourcing Facility | Pharmaceutical Quality System | — | 49 | 1,932 | 2.54% | $0.41 | $ 19.97 |
| Descriptions: 1. Providing critical medicines patients can depend on and clinical practitioners can trust. 2. You can count on SCA Pharma products to deliver the quality and consistency you require. | |||||||||||
| 4 | Expanded text ad | https://scapharma.com/ | SCA Pharma | Leading 503B Organization | 503B Outsourcing Facility | — | 187 | 6,261 | 2.99% | $0.38 | $ 71.39 |
| Descriptions: 1. Exceptional people. Rigorous product testing. State of the art facilities. 2. SCA Pharma provides the highest quality sterile admixtures and pre-filled syringes. | |||||||||||
| Totals: | 530 | 35,816 | 1.48% | $0.43 | $229.49 | ||||||